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Historical
• Gemini 5 (8 day mission)
– Visual Tester in-flight
– Visual acuity 
measurement program 
– Large rectangles at 
ground sites in Texas 
and Australia. 
– No changes noted in 
astronaut visual acuity 
postflight. 
– Duntley et al, 1966
• Apollo 
– Retinal vascular 
photography reveals 
retinal vessels 
“decreased in size” at 
3.5 hours into flight. 
– 100% oxygen 
atmosphere
– No visual acuity 
changes
– Hawkins and 
Zieglschmid, 1975
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Shuttle 
• 10-14 day missions
• Anecdotal reports of 
vision changes, but 
return to baseline. 
• 1 astronaut with 
bilateral lens implants
• No papilledema
cases, but an 
occasional choroidal
fold. 
• 122 crewmembers 
between 1995 and 
1998, 15% indicated 
decrements in near 
vision on orbit. 
Returns to baseline. 
• Paloski et al 2008
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Differences Between Historical 
and Present
• Missions were 5 to 17 
days generally (Skylab a 
notable exception)
• Astronaut age was mean 
of 38
• MRI and OCT not 
available
• Spacecraft ranged from 
5.0 psi to 10.7 psi to 14.7 
psi with varying oxygen 
concentrations
• Missions average 6 
months on ISS
• Astronaut mean age 46.7
• MRI, OCT, Telemedicine 
fundoscopy
• 14.7 psi, 21% oxygen
• Robust exercise suite
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• What is the problem?
– Optic Disc Edema, Globe Flattening, Choroidal Folds, Hyperopic Shifts and Raised 
Intracranial Pressure has occurred in Astronauts During and After Long Duration Space 
Flight
Choroidal Folds
Spectrum
6
Optic Disc Edema Globe Flattening
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Arachnoid Granulations and 
Venous Return
UNCLASSIFIED
The CSF pressure, 
measured at lumbar 
puncture in 
symptomatic astronauts 
has ranged between 22 
and 28 with the patient 
lying on the side. 
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Spinal or Venous Compliance Issue? 
Choroid Plexus? 
• Does the increase in 
blood flow, either 
through fluid shift, 
CO2 vasodilatation, 
or other mechanism 
increase CSF flow or 
production? 
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Potential Plateau Effect Versus 
Continued Evolution
• Of the observed on-orbit papilledema, it 
seemed to stop at the grade 1 to 2 level and 
did not progress over the next month or two 
before de-orbit.  May be a function of plateau 
homeostasis at the higher level of Intracranial 
Pressure. 
• However, one crewmember continued an 
evolution of pathology, and developed a 
cotton wool spot on exam several weeks after 
returning to Earth. 
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Current Evidence Base
• Summary
– 7 long duration male astronauts have experienced in flight and post flight 
symptoms including optic disc edema, globe flattening, choroidal folds, 
hyperopic shifts and raised intracranial pressure (summary in the following 
slide)
– In some of the cases these changes were transient and in others the 
changes are persistent with varying degrees of visual impairment 
– 3.0 Tesla MRI showed some evidence of thickening in asymptomatic 
individuals, including one female astronaut, but without significant 
hyperopic shift of papilledema
– There are also indications that visual and eye anatomy alterations have 
occurred on shuttle flights: not well defined and lack consistent data…
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Cases in Review
• 7 cases, 3/7 had a total of 5 spinal taps. All taps had 
high opening pressures. Opening pressures remained 
above 20 for periods of greater than 18 months. 
• 2/7 were treated. 1 responder, 1 non-responder, with 
same dosage of Diamox. One also failed steroid 
therapy.
• 7/33 for an incidence rate of 21%.  
• Pertinent negatives: 2 astronauts (one male and one 
female) with dual 6 month missions, without 
papilledema or choroidal folds. 
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Treatment Options
• Acetazolamide
– Oral twice daily
– Effective in pressure 
related ICP rises 
(altitude sickness)
– Studies have shown 
limited effectiveness in 
ICP secondary to 
venous causes
– Increases risk of 
kidney stones
• Octreotide
– Daily subcutaneous 
injections
– Effective in pressure 
related ICP rises in 
small n studies, but 
has not had large 
scale studies. 
– Increased risk of gall 
stones. 
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Current Treatment Options, 
Risk Trades
The Elephant in the Room
• Is Vision the only 
system? Is it permanent?  
• Hearing? 
• White matter decay?
• Leukoencephalopathy? 
• Ie- What is the long-term 
effect of low grade 
intracranial hypertension/
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Clinical Implications
• Potential disability 
secondary to vision loss 
in astronauts susceptible 
to papilledema or 
choroidal folds
• Potential for long-term 
sequelae if optic nerve 
cells ischemic
• Potential effect on white 
matter
• Decreased functional 
ability due to IIH
• Unknown contribution to 
space motion sickness, 
asthenia, or functional 
impairments
• Potential to worsen with 
repetitive flights or long 
term space missions
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Does
Spaceflight Induced Intracranial Hypertension 
= Idiopathic Intracranial Hypertension? 
Or 
are the separate entities with a common outcome? 
